Results
|
|
41.
|
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. [electronic resource] by
- Berinstein, N L
- Grillo-López, A J
- White, C A
- Bence-Bruckler, I
- Maloney, D
- Czuczman, M
- Green, D
- Rosenberg, J
- McLaughlin, P
- Shen, D
Producer: 19990204
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 9
Availability: No items available.
|
|
|
42.
|
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. [electronic resource] by
- Davis, T A
- Grillo-López, A J
- White, C A
- McLaughlin, P
- Czuczman, M S
- Link, B K
- Maloney, D G
- Weaver, R L
- Rosenberg, J
- Levy, R
Producer: 20000919
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18
Availability: No items available.
|
|
|
43.
|
Monoclonal antibodies: a new era in the treatment of non-Hodgkin's lymphoma. [electronic resource] by
- Grillo-López, A J
- Dallaire, B K
- McClure, A
- Weaver, R
- Varns, C
- Wei, A
- Allen, R
- Lee, D
- Shen, D
- Leonard, J
- Multani, P
- White, C A
Producer: 20020513
In:
Current pharmaceutical biotechnology vol. 2
Availability: No items available.
|
|
|
44.
|
Rituximab: the first monoclonal antibody approved for the treatment of lymphoma. [electronic resource] by
- Grillo-López, A J
- White, C A
- Dallaire, B K
- Varns, C L
- Shen, C D
- Wei, A
- Leonard, J E
- McClure, A
- Weaver, R
- Cairelli, S
- Rosenberg, J
Producer: 20010809
In:
Current pharmaceutical biotechnology vol. 1
Availability: No items available.
|
|
|
45.
|
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma. [electronic resource] by
- Piro, L D
- White, C A
- Grillo-López, A J
- Janakiraman, N
- Saven, A
- Beck, T M
- Varns, C
- Shuey, S
- Czuczman, M
- Lynch, J W
- Kolitz, J E
- Jain, V
Producer: 19991008
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 10
Availability: No items available.
|
|
|
46.
|
Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab. [electronic resource] by
- Davis, T A
- White, C A
- Grillo-López, A J
- Velásquez, W S
- Link, B
- Maloney, D G
- Dillman, R O
- Williams, M E
- Mohrbacher, A
- Weaver, R
- Dowden, S
- Levy, R
Producer: 20000113
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
|
47.
|
Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody. [electronic resource] by
- Wiseman, G A
- White, C A
- Witzig, T E
- Gordon, L I
- Emmanouilides, C
- Raubitschek, A
- Janakiraman, N
- Gutheil, J
- Schilder, R J
- Spies, S
- Silverman, D H
- Grillo-López, A J
Producer: 19991124
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 5
Availability: No items available.
|
|
|
48.
|
Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma. [electronic resource] by
- Witzig, T E
- White, C A
- Wiseman, G A
- Gordon, L I
- Emmanouilides, C
- Raubitschek, A
- Janakiraman, N
- Gutheil, J
- Schilder, R J
- Spies, S
- Silverman, D H
- Parker, E
- Grillo-López, A J
Producer: 20000128
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
|
49.
|
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity. [electronic resource] by
- Byrd, J C
- Murphy, T
- Howard, R S
- Lucas, M S
- Goodrich, A
- Park, K
- Pearson, M
- Waselenko, J K
- Ling, G
- Grever, M R
- Grillo-Lopez, A J
- Rosenberg, J
- Kunkel, L
- Flinn, I W
Producer: 20010517
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19
Availability: No items available.
|
|
|
50.
|
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. [electronic resource] by
- Maloney, D G
- Grillo-López, A J
- White, C A
- Bodkin, D
- Schilder, R J
- Neidhart, J A
- Janakiraman, N
- Foon, K A
- Liles, T M
- Dallaire, B K
- Wey, K
- Royston, I
- Davis, T
- Levy, R
Producer: 19971020
In:
Blood vol. 90
Availability: No items available.
|
|
|
51.
|
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma. [electronic resource] by
- Wiseman, G A
- White, C A
- Stabin, M
- Dunn, W L
- Erwin, W
- Dahlbom, M
- Raubitschek, A
- Karvelis, K
- Schultheiss, T
- Witzig, T E
- Belanger, R
- Spies, S
- Silverman, D H
- Berlfein, J R
- Ding, E
- Grillo-López, A J
Producer: 20010108
In:
European journal of nuclear medicine vol. 27
Availability: No items available.
|
|
|
52.
|
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. [electronic resource] by
- McLaughlin, P
- Grillo-López, A J
- Link, B K
- Levy, R
- Czuczman, M S
- Williams, M E
- Heyman, M R
- Bence-Bruckler, I
- White, C A
- Cabanillas, F
- Jain, V
- Ho, A D
- Lister, J
- Wey, K
- Shen, D
- Dallaire, B K
Producer: 19980831
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|